Publications

Original publication in peer-reviewed journals:

Google Scholar List

(1)
Wiczling, P.; Kamedulska, A.; Kubik, L. Application of Bayesian Multilevel Modeling in the Quantitative Structure-Retention Relationship Studies of Heterogeneous Compounds. ANALYTICAL CHEMISTRY, 2021, 93, 6961–6971. https://doi.org/10.1021/acs.analchem.0c05227.

(2)
Bienert, A.; Sobczynski, P.; Mlodawska, K.; Hartmann-Sobczynska, R.; Grzeskowiak, E.; Wiczling, P. The Influence of Cardiac Output on Propofol and Fentanyl Pharmacokinetics and Pharmacodynamics in Patients Undergoing Abdominal Aortic Surgery. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2020, 47, 583–596. https://doi.org/10.1007/s10928-020-09712-1.

(3)
Ber, J.; Wiczling, P.; Holysz, M.; Klupczynska, A.; Bartkowska-Sniatkowska, A.; Bieda, K.; Smuszkiewicz, P.; Nowicka, M.; Zuranski, L.; Sobczynski, P.; Matysiak, J.; Grzeskowiak, E.; Bienert, A. Population Pharmacokinetic Model of Dexmedetomidine in a Heterogeneous Group of Patients. JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 60, 1461–1473. https://doi.org/10.1002/jcph.1647.

(4)
Szczesny, D.; Moloniewicz, K.; Markuszewski, M. J.; Wiczling, P. Proof-of-Concept Study on Improved Efficacy of RHuEPO Administered as a Long-Term Infusion in Rats. PHARMACOLOGICAL REPORTS, 2020, 72, 1264–1270. https://doi.org/10.1007/s43440-020-00150-x.

(5)
Borsuk-De Moor, A.; Sysiak-Slawecka, J.; Rypulak, E.; Borys, M.; Piwowarczyk, P.; Raszewski, G.; Onichimowski, D.; Czuczwar, M.; Wiczling, P. Nonstationary Pharmacokinetics of Caspofungin in ICU Patients. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64. https://doi.org/10.1128/AAC.00345-20.

(6)
Warzybok, J.; Bienert, A.; Borsuk-De Moor, A.; Plotek, W.; Kulinska, K.; Czerniak, K.; Billert, H.; Klupczynska, A.; Matysiak, J.; Grzeskowiak, E.; Wiczling, P. Population Analysis to Assess the Influence of Age and Body Weight on Pharmacokinetics and Pharmacodynamics of Dexmedetomidine in New Zealand White Rabbits. BIOPHARMACEUTICS & DRUG DISPOSITION, 2020, 41, 307–316. https://doi.org/10.1002/bdd.2248.

(7)
Onichimowski, D.; Bedzkowska, A.; Ziolkowski, H.; Jaroszewski, J.; Borys, M.; Czuczwar, M.; Wiczling, P. Population Pharmacokinetics of Standard-Dose Meropenem in Critically Ill Patients on Continuous Renal Replacement Therapy: A Prospective Observational Trial. PHARMACOLOGICAL REPORTS, 2020, 72, 719–729. https://doi.org/10.1007/s43440-020-00104-3.

(8)
Wiczling, P.; Daghir-Wojtkowiak, E.; Kaliszan, R.; Markuszewski, M. J.; Limon, J.; Koczkowska, M.; Stukan, M.; Kuzniacka, A.; Ratajska, M. Bayesian Multilevel Model of Micro RNA Levels in Ovarian-Cancer and Healthy Subjects. PLOS ONE, 2019, 14. https://doi.org/10.1371/journal.pone.0221764.

(9)
Kubik, L.; Kaliszan, R.; Wiczling, P. Analysis of Isocratic-Chromatographic-Retention Data Using Bayesian Multilevel Modeling. ANALYTICAL CHEMISTRY, 2018, 90, 13670–13679. https://doi.org/10.1021/acs.analchem.8b04033.

(10)
Estepp, J. H.; Wiczling, P.; Moen, J.; Kang, G.; Mack, J. M.; Liem, R.; Panepinto, J. A.; Garg, U.; Kearns, G.; Neville, K. A. Hydroxycarbamide in Children with Sickle Cell Anaemia after First-Dose vs. Chronic Therapy: Pharmacokinetics and Predictive Models for Drug Exposure. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 84, 1478–1485. https://doi.org/10.1111/bcp.13426.

(11)
Bartosinska, E.; Borsuk-De Moor, A.; Siluk, D.; Markuszewski, M. J.; Wiczling, P. Ionization of Tocopherols and Tocotrienols in Atmospheric Pressure Chemical Ionization. RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2018, 32, 919–927. https://doi.org/10.1002/rcm.8124.

(12)
Wiczling, P. Analyzing Chromatographic Data Using Multilevel Modeling. ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2018, 410, 3905–3915. https://doi.org/10.1007/s00216-018-1061-3.

(13)
Nguyen, L. M.; Singh, A. P.; Wiczling, P.; Krzyzanski, W. Dynamics of Erythropoietic Biomarkers in Response to Treatment With Erythropoietin in Belgrade Rats. FRONTIERS IN PHARMACOLOGY, 2018, 9. https://doi.org/10.3389/fphar.2018.00316.

(14)
Smuszkiewicz, P.; Wiczling, P.; Ber, J.; Warzybok, J.; Malkiewicz, T.; Matysiak, J.; Klupczynska, A.; Trojanowska, I.; Kokot, Z.; Grzeskowiak, E.; Krzyzanski, W.; Bienert, A. Pharmacokinetics of Dexmedetomidine during Analgosedation in ICU Patients. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2018, 45, 277–284. https://doi.org/10.1007/s10928-017-9564-7.

(15)
Borsuk-De Moor, A.; Rypulak, E.; Potrec, B.; Piwowarczyk, P.; Borys, M.; Sysiak, J.; Onichimowski, D.; Raszewski, G.; Czuczwar, M.; Wiczling, P. Population Pharmacokinetics of High-Dose Tigecycline in Patients with Sepsis or Septic Shock. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62. https://doi.org/10.1128/AAC.02273-17.

(16)
Wiczling, P. Evaluation of Sequential Bayesian-Based Method Development Procedures for Chromatographic Problems Involving One, Two, and Three Analytes. SEPARATION SCIENCE PLUS, 2018, 1, 63–75. https://doi.org/10.1002/sscp.201700037.

(17)
Wiczling, P.; Daghir-Wojtkowiak, E.; Mpanga, A. Y.; Szczesny, D.; Kaliszan, R.; Markuszewski, M. J. How to Model Temporal Changes in Nontargeted Metabolomics Study? A Bayesian Multilevel Perspective. JOURNAL OF SEPARATION SCIENCE, 2017, 40, 4667–4676. https://doi.org/10.1002/jssc.201700918.

(18)
Mioduszewska, K.; Dolzonek, J.; Wyrzykowski, D.; Kubik, L.; Wiczling, P.; Sikorska, C.; Tonski, M.; Kaczynski, Z.; Stepnowski, P.; Bialk-Bielinska, A. Overview of Experimental and Computational Methods for the Determination of the PKa Values of 5-Fluorouracil, Cyclophosphamide, Ifosfamide, Imatinib and Methotrexate. TRAC-TRENDS IN ANALYTICAL CHEMISTRY, 2017, 97, 283–296. https://doi.org/10.1016/j.trac.2017.09.009.

(19)
Kubik, L.; Wiczling, P.; Kaliszan, R. PH-Gradient Liquid Chromatography: Fundamentals and Examples. JOURNAL OF AOAC INTERNATIONAL, 2017, 100, 1590–1598. https://doi.org/10.5740/jaoacint.17-0205.

(20)
Borsuk, A.; Woloszczuk-Gebicka, B.; Bartkowska-Sniatkowska, A.; Rosada-Kurasinska, J.; Bienert, A.; Wiczling, P. Flip-Flop Phenomenon in Epidural Sufentanil Pharmacokinetics: A Population Study in Children and Infants. JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 57, 1194–1206. https://doi.org/10.1002/jcph.912.

(21)
Krzyzanski, W.; Wiczling, P.; Gebre, A. Age-Structured Population Model of Cell Survival. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44, 305–316. https://doi.org/10.1007/s10928-017-9520-6.

(22)
Daghir-Wojtkowiak, E.; Wiczling, P.; Waszczuk-Jankowska, M.; Kaliszan, R.; Markuszewski, M. J. Multilevel Pharmacokinetics-Driven Modeling of Metabolomics Data. METABOLOMICS, 2017, 13. https://doi.org/10.1007/s11306-017-1164-4.

(23)
Szerkus, O.; Struck-Lewicka, W.; Kordalewska, M.; Bartosinska, E.; Bujak, R.; Borsuk, A.; Bienert, A.; Bartkowska-Sniatkowska, A.; Warzybok, J.; Wiczling, P.; Nasal, A.; Kaliszan, R.; Markuszewski, M. J.; Siluk, D. HPLC-MS/MS Method for Dexmedetomidine Quantification with Design of Experiments Approach: Application to Pediatric Pharmacokinetic Study. BIOANALYSIS, 2017, 9, 395–406. https://doi.org/10.4155/bio-2016-0242.

(24)
Mack, J. M.; Wiczling, P.; Moen, J.; Kang, G.; Liem, R. I.; Panepinto, J. A.; Kearns, G.; Neville, K. A.; Estepp, J. H. Pharmacokinetics in Children with Sickle Cell Anemia Following Single Dose Versus Chronic Treatment with Hydroxyurea. BLOOD, 2016, 128. https://doi.org/10.1182/blood.V128.22.1314.1314.

(25)
Smuszkiewicz, P.; Wiczling, P.; Przybylowski, K.; Borsuk, A.; Trojanowska, I.; Paterska, M.; Matysiak, J.; Kokot, Z.; Grzeskowiak, E.; Bienert, A. The Pharmacokinetics of Propofol in ICU Patients Undergoing Long-Term Sedation. BIOPHARMACEUTICS & DRUG DISPOSITION, 2016, 37, 456–466. https://doi.org/10.1002/bdd.2028.

(26)
Szerkus, O.; Jacyna, J.; Wiczling, P.; Gibas, A.; Sieczkowski, M.; Siluk, D.; Matuszewski, M.; Kaliszan, R.; Markuszewski, M. J. Ultra-High Performance Liquid Chromatographic Determination of Levofloxacin in Human Plasma and Prostate Tissue with Use of Experimental Design Optimization Procedures. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2016, 1029, 48–59. https://doi.org/10.1016/j.jchromb.2016.06.051.

(27)
Kubik, L.; Wiczling, P. Quantitative Structure-(Chromatographic) Retention Relationship Models for Dissociating Compounds. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2016, 127, 176–183. https://doi.org/10.1016/j.jpba.2016.02.050.

(28)
Wiczling, P.; Bieda, K.; Przybylowski, K.; Hartmann-Sobczynska, R.; Borsuk, A.; Matysiak, J.; Kokot, Z. J.; Sobczynski, P.; Grzeskowiak, E.; Bienert, A. Pharmacokinetics and Pharmacodynamics of Propofol and Fentanyl in Patients Undergoing Abdominal Aortic Surgery – a Study of Pharmacodynamic Drug-Drug Interactions. BIOPHARMACEUTICS & DRUG DISPOSITION, 2016, 37, 252–263. https://doi.org/10.1002/bdd.2009.

(29)
Wiczling, P.; Bartkowska-Sniatkowska, A.; Szerkus, O.; Siluk, D.; Rosada-Kurasinska, J.; Warzybok, J.; Borsuk, A.; Kaliszan, R.; Grzeskowiak, E.; Bienert, A. The Pharmacokinetics of Dexmedetomidine during Long-Term Infusion in Critically Ill Pediatric Patients. A Bayesian Approach with Informative Priors. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2016, 43, 315–324. https://doi.org/10.1007/s10928-016-9474-0.

(30)
Estepp, J. H.; Melloni, C.; Thornburg, C. D.; Wiczling, P.; Rogers, Z.; Rothman, J. A.; Green, N. S.; Liem, R.; Brandow, A. M.; Crary, S. E.; Howard, T. H.; Morris, M. H.; Lewandowski, A.; Garg, U.; Jusko, W. J.; Neville, K. A.; Act, B. P. C. Pharmacokinetics and Bioequivalence of a Liquid Formulation of Hydroxyurea in Children With Sickle Cell Anemia. JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56, 298–306. https://doi.org/10.1002/jcph.598.

(31)
Wiczling, P.; Kaliszan, R. How Much Can We Learn from a Single Chromatographic Experiment? A Bayesian Perspective. ANALYTICAL CHEMISTRY, 2016, 88, 997–1002. https://doi.org/10.1021/acs.analchem.5b03859.

(32)
Bartkowska-Sniatkowska, A.; Bienert, A.; Wiczling, P.; Rosada-Kurasinska, J.; Zielinska, M.; Warzybok, J.; Borsuk, A.; Tibboel, D.; Kaliszan, R.; Grzeskowiak, E. Pharmacokinetics of Sufentanil during Long-Term Infusion in Critically Ill Pediatric Patients. JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56, 109–115. https://doi.org/10.1002/jcph.577.

(33)
Kubik, L.; Struck-Lewicka, W.; Kaliszan, R.; Wiczling, P. Simultaneous Determination of Hydrophobicity and Dissociation Constant for a Large Set of Compounds by Gradient Reverse Phase High Performance Liquid Chromatography-Mass Spectrometry Technique. JOURNAL OF CHROMATOGRAPHY A, 2015, 1416, 31–37. https://doi.org/10.1016/j.chroma.2015.09.003.

(34)
Wiczling, P.; Kubik, L.; Kaliszan, R. Maximum A Posteriori Bayesian Estimation of Chromatographic Parameters by Limited Number of Experiments. ANALYTICAL CHEMISTRY, 2015, 87, 7241–7249. https://doi.org/10.1021/acs.analchem.5b01195.

(35)
Daghir-Wojtkowiak, E.; Wiczling, P.; Bocian, S.; Kubik, L.; Koslinski, P.; Buszewski, B.; Kaliszan, R.; Markuszewski, M. J. Least Absolute Shrinkage and Selection Operator and Dimensionality Reduction Techniques in Quantitative Structure Retention Relationship Modeling of Retention in Hydrophilic Interaction Liquid Chromatography. JOURNAL OF CHROMATOGRAPHY A, 2015, 1403, 54–62. https://doi.org/10.1016/j.chroma.2015.05.025.

(36)
Przybylowski, K.; Tyczka, J.; Szczesny, D.; Bienert, A.; Wiczling, P.; Kut, K.; Plenzler, E.; Kaliszan, R.; Grzeskowiak, E. Pharmacokinetics and Pharmacodynamics of Propofol in Cancer Patients Undergoing Major Lung Surgery. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2015, 42, 111–122. https://doi.org/10.1007/s10928-015-9404-6.

(37)
Bienert, A.; Wawrzyniak, K.; Wiczling, P.; Przybylowski, K.; Kokot, Z. J.; Matysiak, J.; Pachutko, A.; Jozefowicz, M.; Kusza, K.; Grzeskowiak, E. Melatonin and Clonidine Premedication Has Similar Impact on the Pharmacokinetics and Pharmacodynamics of Propofol Target Controlled-Infusions. JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 55, 307–316. https://doi.org/10.1002/jcph.401.

(38)
Bartkowska-Sniatkowska, A.; Bienert, A.; Wiczling, P.; Owczarek, M.; Rosada-Kurasinska, J.; Grzeskowiak, M.; Matysiak, J.; Kokot, Z. J.; Kaliszan, R.; Grzeskowiak, E. Pharmacokinetics and Pharmacodynamics of Propofol in Children Undergoing Different Types of Surgeries. PHARMACOLOGICAL REPORTS, 2014, 66, 821–829. https://doi.org/10.1016/j.pharep.2014.04.012.

(39)
Wiczling, P.; Liem, R. I.; Panepinto, J. A.; Garg, U.; Abdel-Rahman, S. M.; Kearns, G. L.; Neville, K. A. Population Pharmacokinetics of Hydroxyurea for Children and Adolescents with Sickle Cell Disease. JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 54, 1016–1022. https://doi.org/10.1002/jcph.303.

(40)
Wiczling, P.; Krzyzanski, W.; Zychlinska, N.; Lewandowski, K.; Kaliszan, R. The Quantification of Reticulocyte Maturation and Neocytolysis in Normal and Erythropoietin Stimulated Rats. BIOPHARMACEUTICS & DRUG DISPOSITION, 2014, 35, 330–340. https://doi.org/10.1002/bdd.1902.

(41)
Wiczling, P.; Struck-Lewicka, W.; Kubik, L.; Siluk, D.; Markuszewski, M. J.; Kaliszan, R. The Simultaneous Determination of Hydrophobicity and Dissociation Constant by Liquid Chromatography-Mass Spectrometry. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2014, 94, 180–187. https://doi.org/10.1016/j.jpba.2014.01.038.

(42)
Szerkus, O.; Wolska, E.; Struck-Lewicka, W.; Siluk, D.; Radwanska, A.; Wiczling, P.; Chorazewicz, J.; Sznitowska, M.; Markuszewski, M. J.; Kaliszan, R. Development and Validation of UHPLC Method for the Determination of Cyclosporine A in Biological Samples. BIOMEDICAL CHROMATOGRAPHY, 2014, 28, 802–809. https://doi.org/10.1002/bmc.3132.

(43)
Bienert, A.; Plotek, W.; Wiczling, P.; Kostrzewski, B.; Kaminska, A.; Billert, H.; Szczesny, D.; Zaba, C.; Tezyk, A.; Buda, K.; Bednarek, E.; Kaliszan, R.; Grzeskowiak, E. The Influence of the Time of Day on Midazolam Pharmacokinetics and Pharmacodynamics in Rabbits. PHARMACOLOGICAL REPORTS, 2014, 66, 143–152. https://doi.org/10.1016/j.pharep.2013.06.009.

(44)
Bienert, A.; Bartkowska-Sniatkowska, A.; Wiczling, P.; Rosada-Kurasinska, J.; Grzeskowiak, M.; Zaba, C.; Tezyk, A.; Sokolowska, A.; Kaliszan, R.; Grzeskowiak, E. Assessing Circadian Rhythms during Prolonged Midazolam Infusion in the Pediatric Intensive Care Unit (PICU) Children. PHARMACOLOGICAL REPORTS, 2013, 65, 107–121. https://doi.org/10.1016/S1734-1140(13)70969-1.

(45)
Struck, W.; Wiczling, P.; Waszczuk-Jankowska, M.; Kaliszan, R.; Markuszewski, M. J. New Supervised Alignment Method as a Preprocessing Tool for Chromatographic Data in Metabolomic Studies. JOURNAL OF CHROMATOGRAPHY A, 2012, 1256, 150–159. https://doi.org/10.1016/j.chroma.2012.07.084.

(46)
Wiczling, P.; Nasal, A.; Kubik, L.; Kaliszan, R. A New PH/Organic Modifier Gradient RP HPLC Method for Convenient Determination of Lipophilicity and Acidity of Drugs as Applied to Established Imidazoline Agents. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 47, 1–5. https://doi.org/10.1016/j.ejps.2012.04.021.

(47)
Bienert, A.; Wiczling, P.; Grzeskowiak, E.; Cywinski, J. B.; Kusza, K. Potential Pitfalls of Propofol Target Controlled Infusion Delivery Related to Its Pharmacokinetics and Pharmacodynamics. PHARMACOLOGICAL REPORTS, 2012, 64, 782–795. https://doi.org/10.1016/S1734-1140(12)70874-5.

(48)
Di Tullio, M.; Maccallini, C.; Ammazzalorso, A.; Giampietro, L.; Amoroso, R.; De Filippis, B.; Fantacuzzi, M.; Wiczling, P.; Kaliszan, R. QSAR, QSPR and QSRR in Terms of 3-D-MoRSE Descriptors for In Silico Screening of Clofibric Acid Analogues. MOLECULAR INFORMATICS, 2012, 31, 453–458. https://doi.org/10.1002/minf.201200001.

(49)
Wiczling, P.; Bienert, A.; Sobczynski, P.; Hartmann-Sobczynska, R.; Bieda, K.; Marcinkowska, A.; Malatynska, M.; Kaliszan, R.; Grzeskowiak, E. Pharmacokinetics and Pharmacodynamics of Propofol in Patients Undergoing Abdominal Aortic Surgery. PHARMACOLOGICAL REPORTS, 2012, 64, 113–122. https://doi.org/10.1016/S1734-1140(12)70737-5.

(50)
Wiczling, P.; Liem, R. I.; Panepinto, J. A.; Garg, U.; Abdel-Rahman, S. M.; Kearns, G. L.; Neville, K. A. Population Pharmacokinetic (PK) Modeling of Hydroxyurea for Therapeutic Drug Monitoring Applications in Children and Adolescents with Sickle Cell Disease. BLOOD, 2011, 118, 936.

(51)
Kaliszan, R.; Wiczling, P. Gradient Reversed-Phase High-Performance Chromatography of Ionogenic Analytes. TRAC-TRENDS IN ANALYTICAL CHEMISTRY, 2011, 30, 1372–1381. https://doi.org/10.1016/j.trac.2011.05.006.

(52)
Kaliszan, R.; Wiczling, P.; Markuszewski, M. J.; Al-Haj, M. A. Thermodynamic vs. Extrathermodynamic Modeling of Chromatographic Retention. JOURNAL OF CHROMATOGRAPHY A, 2011, 1218, 5120–5130. https://doi.org/10.1016/j.chroma.2011.05.077.

(53)
Perisic-Janjic, N.; Kaliszan, R.; Wiczling, P.; Milosevic, N.; Uscumlic, G.; Banjac, N. Reversed-Phase TLC and HPLC Retention Data in Correlation Studies with in Silico Molecular Descriptors and Druglikeness Properties of Newly Synthesized Anticonvulsant Succinimide Derivatives. MOLECULAR PHARMACEUTICS, 2011, 8, 555–563. https://doi.org/10.1021/mp100373d.

(54)
Bienert, A.; Wiczling, P.; Zaba, C.; Zaba, Z.; Wolc, A.; Marciniak, R.; Grzeskowiak, E.; Kusza, K. Influence of Demographic Factors, Basic Blood Test Parameters and Opioid Type on Propofol Pharmacokinetics and Pharmacodynamics in ASA I-III Patients. ARZNEIMIT℡FORSCHUNG-DRUG RESEARCH, 2011, 61, 545–552.

(55)
Bienert, A.; Plotek, W.; Zawidzka, I.; Ratajczak, N.; Szczesny, D.; Wiczling, P.; Kokot, Z. J.; Matysiak, J.; Grzeskowiak, E. Influence of Time of Day on Propofol Pharmacokinetics and Pharmacodynamics in Rabbits. CHRONOBIOLOGY INTERNATIONAL, 2011, 28, 318–329. https://doi.org/10.3109/07420528.2011.560317.

(56)
Hale, G.; Rebello, P.; Al Bakir, I.; Bolam, E.; Wiczling, P.; Jusko, W. J.; Vandemeulebroucke, E.; Keymeulen, B.; Mathieu, C.; Ziegler, A.-G.; Chatenoud, L.; Waldmann, H. Pharmacokinetics and Antibody Responses to the CD3 Antibody Otelixizumab Used in the Treatment of Type 1 Diabetes. JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50, 1238–1248. https://doi.org/10.1177/0091270009356299.

(57)
Krzyzanski, W.; Wiczling, P.; Lowe, P.; Pigeolet, E.; Fink, M.; Berghout, A.; Balser, S. Population Modeling of Filgrastim PK-PD in Healthy Adults Following Intravenous and Subcutaneous Administrations. JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50, 101S-112S. https://doi.org/10.1177/0091270010376966.

(58)
Bienert, A.; Kusza, K.; Wawrzyniak, K.; Grzeskowiak, E.; Kokot, Z. J.; Matysiak, J.; Grabowski, T.; Wolc, A.; Wiczling, P.; Regulski, M. Assessing Circadian Rhythms in Propofol PK and PD during Prolonged Infusion in ICU Patients. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2010, 37, 289–304. https://doi.org/10.1007/s10928-010-9161-5.

(59)
Wiczling, P.; Kaliszan, R. Retention Time and Peak Width in the Combined PH/Organic Modifier Gradient High Performance Liquid Chromatography. JOURNAL OF CHROMATOGRAPHY A, 2010, 1217, 3375–3381. https://doi.org/10.1016/j.chroma.2010.03.003.

(60)
Wiczling, P.; Kaliszan, R. PH Gradient as a Tool for the Separation of Ionizable Analytes in Reversed-Phase High-Performance Chromatography. ANALYTICAL CHEMISTRY, 2010, 82, 3692–3698. https://doi.org/10.1021/ac100023z.

(61)
Wiczling, P.; Rosenzweig, M.; Vaickus, L.; Jusko, W. J. Pharmacokinetics and Pharmacodynamics of a Chimeric/Humanized Anti-CD3 Monoclonal Antibody, Otelixizumab (TRX4), in Subjects With Psoriasis and With Type 1 Diabetes Mellitus. JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50, 494–506. https://doi.org/10.1177/0091270009349376.

(62)
Wiczling, P.; Ait-Oudhia, S.; Krzyzanski, W. Flow Cytometric Analysis of Reticulocyte Maturation After Erythropoietin Administration in Rats. CYTOMETRY PART A, 2009, 75A, 584–592. https://doi.org/10.1002/cyto.a.20736.

(63)
Wiczling, P.; Lowe, P.; Pigeolet, E.; Luedicke, F.; Balser, S.; Krzyzanski, W. Population Pharmacokinetic Modelling of Filgrastim in Healthy Adults Following Intravenous and Subcutaneous Administrations. CLINICAL PHARMACOKINETICS, 2009, 48, 817–826. https://doi.org/10.2165/11318090-000000000-00000.

(64)
Wiczling, P.; Waszczuk-Jankowska, M.; Markuszewski, M. J.; Kaliszan, R. The Application of Gradient Reversed-Phase High-Performance Liquid Chromatography to the PK(a) and Log k(w) Determination of Polyprotic Analytes. JOURNAL OF CHROMATOGRAPHY A, 2008, 1214, 109–114. https://doi.org/10.1016/j.chroma.2008.10.085.

(65)
Wiczling, P.; Kaliszan, R. Influence of PH on Retention in Linear Organic Modifier Gradient RP HPLC. ANALYTICAL CHEMISTRY, 2008, 80, 7855–7861. https://doi.org/10.1021/ac801093u.

(66)
Wiczling, P.; Krzyzanski, W. Flow Cytometric Assessment of Homeostatic Aging of Reticulocytes in Rats. EXPERIMENTAL HEMATOLOGY, 2008, 36, 119–127. https://doi.org/10.1016/j.exphem.2007.09.002.

(67)
Wiczling, P.; Krzyzanski, C. Comparison of Homeostatic Reticulocyte Aging between Normal and Belgrade Rats Using Flow Cytometry. BLOOD, 2007, 110, 788A.

(68)
Wiczling, P.; Krzyzanski, W. Method of Determination of the Reticulocyte Age Distribution from Flow Cytometry Count by a Structured-Population Model. CYTOMETRY PART A, 2007, 71A, 460–467. https://doi.org/10.1002/cyto.a.20408.

(69)
Wiczling, P.; Kawczak, P.; Nasal, A.; Kaliszan, R. Simultaneous Determination of PK(a) and Lipophilicity by Gradient RP HPLC. ANALYTICAL CHEMISTRY, 2006, 78, 239–249. https://doi.org/10.1021/ac0512103.

(70)
Kaliszan, M.; Hauser, R.; Kaliszan, R.; Wiczling, P.; Buczynski, J.; Penkowski, M. Verification of the Exponential Model of Body Temperature Decrease after Death in Pigs. EXPERIMENTAL PHYSIOLOGY, 2005, 90, 727–738. https://doi.org/10.1113/expphysiol.2005.030551.

(71)
Siluk, D.; Markuszewski, M.; Baczek, T.; Wiczling, P.; Marszall, M.; Frackowiak, T.; Radwanska, A.; Damasiewicz, B.; Kaliszan, R.; Sobiczewski, W.; Rynkiewicz, A. Application of an HPLC Method to the Determination of Celiprolol Bioequivalence after Single Oral Dose. JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45, 1089.

(72)
Kaliszan, R.; Wiczling, P. Theoretical Opportunities and Actual Limitations of PH Gradient HPLC. ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2005, 382, 718–727. https://doi.org/10.1007/s00216-004-3023-1.

(73)
Wiczling, P.; Markuszewski, M.; Kaliszan, M.; Galer, K.; Kaliszan, R. Combined PH/Organic Solvent Gradient HPLC in Analysis of Forensic Material. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2005, 37, 871–875. https://doi.org/10.1016/j.jpba.2004.06.031.

(74)
Baczek, T.; Wiczling, P.; Marszall, M.; Vander Heyden, Y.; Kaliszan, R. Prediction of Peptide Retention at Different HPLC Conditions from Multiple Linear Regression Models. JOURNAL OF PROTEOME RESEARCH, 2005, 4, 555–563. https://doi.org/10.1021/pr049780r.

(75)
Wiczling, P.; Markuszewski, M.; Kaliszan, M.; Kaliszan, R. PH/Organic Solvent Double-Gradient Reversed-Phase HPLC. ANALYTICAL CHEMISTRY, 2005, 77, 449–458. https://doi.org/10.1021/ac049092r.

(76)
Kaliszan, R.; Wiczling, P.; Markuszewski, M. PH Gradient High-Performance Liquid Chromatography: Theory and Applications. JOURNAL OF CHROMATOGRAPHY A, 2004, 1060, 165–175. https://doi.org/10.1016/j.chroma.2004.04.081.

(77)
Kaliszan, R.; Markuszewski, M.; Wiczling, P. Combined PH/Organic Modifier Double Gradient Reversed-Phase HPLC. POLISH JOURNAL OF CHEMISTRY, 2004, 78, 1047–1056.

(78)
Wiczling, P.; Markuszewski, M.; Kaliszan, R. Determination of PK(a) by PH Gradient Reversed-Phase HPLC. ANALYTICAL CHEMISTRY, 2004, 76, 3069–3077. https://doi.org/10.1021/ac049807q.

(79)
Markuszewski, M.; Wiczling, P.; Kaliszan, R. High-Throughput Evaluation of Lipophilicity and Acidity by New Gradient HPLC Methods. COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2004, 7, 281–289.

(80)
Kaliszan, R.; Wiczling, P.; Markuszewski, M. PH Gradient Reversed-Phase HPLC. ANALYTICAL CHEMISTRY, 2004, 76, 749–760. https://doi.org/10.1021/ac034999v.